NEW YORK, July 14, Jul 14, 2014 (GLOBE NEWSWIRE via COMTEX) — NeoStem, Inc. (Nasdaq:NBS), a leader in the emerging cellular therapy industry, announced today that Frost & Sullivan has awarded the Company its 2014 North American Cell Therapeutics Technology Innovation Leadership Award. The award is part of Frost & Sullivan’s Best Practice Award series, recognizing companies that have demonstrated excellence in devising strong growth strategies and robustly implementing these approaches. NeoStem was recognized for its outstanding achievement and superiorRead more
- Video News on Precision Therapeutics Inc (Nasdaq: AIPT) – Company Projects Meaningful STREAMWAY System Sales in Europe in the Second Half of 2018
- The Largest Pot Stock in the World Is Moving to the NYSE
- Results of CytoDyn’s PRO 140 CD01 Trial and Extension Study Published in HIV Clinical Trials
- GeoVax Awarded NIH Grant for Novel Zika Vaccine
- Airborne Wireless Network Announces Pricing of $8,000,000 Public Offering of Convertible Preferred Stock and Warrants
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More